These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24103199)

  • 61. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antileishmanial potential of immunomodulator gallic acid against experimental murine visceral leishmaniasis.
    Keshav P; Goyal DK; Kaur S
    Parasite Immunol; 2021 Oct; 43(10-11):e12875. PubMed ID: 34347892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nerve growth factor promotes killing of Leishmania donovani by macrophages through the induction of hydrogen peroxide.
    Chiba R; Amagai Y; Tanaka A; Katakura K; Matsuda H
    Microbes Infect; 2014 Aug; 16(8):702-6. PubMed ID: 24937592
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model.
    Keshav P; Goyal DK; Kaur S
    Med Microbiol Immunol; 2023 Feb; 212(1):35-51. PubMed ID: 36399160
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs.
    Gogulamudi VR; Dubey ML; Kaul D; Hubert DJ; Kandimalla R; Sehgal R
    Sci Rep; 2019 Jun; 9(1):8531. PubMed ID: 31189939
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SAR refinement of antileishmanial N(2),N(4)-disubstituted quinazoline-2,4-diamines.
    Zhu X; Van Horn KS; Barber MM; Yang S; Wang MZ; Manetsch R; Werbovetz KA
    Bioorg Med Chem; 2015 Aug; 23(16):5182-9. PubMed ID: 25749014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations.
    Joice AC; Yang S; Farahat AA; Meeds H; Feng M; Li J; Boykin DW; Wang MZ; Werbovetz KA
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061761
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Th-1 biased immunomodulation and synergistic antileishmanial activity of stable cationic lipid-polymer hybrid nanoparticle: biodistribution and toxicity assessment of encapsulated amphotericin B.
    Asthana S; Jaiswal AK; Gupta PK; Dube A; Chourasia MK
    Eur J Pharm Biopharm; 2015 Jan; 89():62-73. PubMed ID: 25477079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Formulation and evaluation of oil-in-water emulsions of piperine in visceral leishmaniasis.
    Veerareddy PR; Vobalaboina V; Nahid A
    Pharmazie; 2004 Mar; 59(3):194-7. PubMed ID: 15074591
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of Withania somnifera chemotypes NMITLI - 101R, 118R and Withaferin A against experimental visceral leishmaniasis.
    Tripathi CD; Gupta R; Kushawaha PK; Mandal C; Misra Bhattacharya S; Dube A
    Parasite Immunol; 2014 Jun; 36(6):253-65. PubMed ID: 24830833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunotherapeutic potential of Codonopsis clematidea and naringenin against visceral leishmaniasis.
    Kaur G; Chauhan K; Kaur S
    Biomed Pharmacother; 2018 Dec; 108():1048-1061. PubMed ID: 30372805
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice.
    Mutiso JM; Macharia JC; Barasa M; Taracha E; Bourdichon AJ; Gicheru MM
    Rev Inst Med Trop Sao Paulo; 2011; 53(3):129-32. PubMed ID: 21755234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adjuvant effect of Asparagus racemosus Willd. derived saponins in antibody production, allergic response and pro-inflammatory cytokine modulation.
    Tiwari N; Gupta VK; Pandey P; Patel DK; Banerjee S; Darokar MP; Pal A
    Biomed Pharmacother; 2017 Feb; 86():555-561. PubMed ID: 28024292
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.
    Freitas CS; Lage DP; Oliveira-da-Silva JA; Costa RR; Mendonça DVC; Martins VT; Reis TAR; Antinarelli LMR; Machado AS; Tavares GSV; Ramos FF; Brito RCF; Ludolf F; Chávez-Fumagalli MA; Roatt BM; Ramos GS; Munkert J; Ottoni FM; Campana PRV; Duarte MC; Gonçalves DU; Coimbra ES; Braga FC; Pádua RM; Coelho EAF
    Parasite; 2021; 28():38. PubMed ID: 33851916
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis.
    Kaur G; Chauhan K; Kaur S
    Parasitology; 2019 Sep; 146(11):1440-1450. PubMed ID: 31104636
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis.
    Mitra M; Mandal AK; Chatterjee TK; Das N
    J Drug Target; 2005 Jun; 13(5):285-93. PubMed ID: 16199372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective efficacy of Chlorophytum borivilianum root extract against murine visceral leishmaniasis by immunomodulating the host responses.
    Kaur R; Kaur S
    J Ayurveda Integr Med; 2020; 11(1):53-61. PubMed ID: 30120057
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Suppression of Leishmania donovani by oral administration of a bis(benzyl)polyamine analog.
    Baumann RJ; McCann PP; Bitonti AJ
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1403-7. PubMed ID: 1929300
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani.
    Fournet A; Gantier JC; Gautheret A; Leysalles L; Munos MH; Mayrargue J; Moskowitz H; Cavé A; Hocquemiller R
    J Antimicrob Chemother; 1994 Mar; 33(3):537-44. PubMed ID: 8040117
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis.
    Keerti ; Yadav NK; Joshi S; Ratnapriya S; Sahasrabuddhe AA; Dube A
    J Microbiol Immunol Infect; 2023 Feb; 56(1):163-171. PubMed ID: 35835687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.